Trupanion, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRUP research report →
Range $29 – $42
Price Chart
About the company
Trupanion, Inc. provides monthly subscription-based medical insurance for canine and feline companions across the United States, Canada, Puerto Rico, and Australia. The company's operations are divided into two main categories: Subscription Business and Other Business, serving both pet owners and veterinary professionals.
- CEO
- Margaret Rosemary Maria Tooth
- IPO
- 2014
- Employees
- 1,121
- HQ
- Seattle, WA, US
Get TickerSpark's AI analysis on TRUP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $1.54B
- P/E
- 58.30
- Fwd P/E
- 52.17
- PEG
- 0.78
- P/S
- 0.99
- P/B
- 3.88
- EV/EBITDA
- 26.92
- Div Yield
- 0.00%
- Gross Margin
- 22.53%
- Op Margin
- 1.81%
- Net Margin
- 1.71%
- ROE
- 6.71%
- ROIC
- 4.81%
Latest fiscal year · YoY change
- Revenue
- $1.44B+11.9%
- Gross Profit
- $410.33M+129.5%
- Op Income
- $21.99M
- Net Income
- $19.43M+301.7%
- EPS
- $0.45+295.7%
- OCF Growth
- +85.3%
- FCF Growth
- +95.4%
- 52W High
- $38.87
- 52W Low
- $21.16
- 50D MA
- $28.77
- 200D MA
- $26.78
- Beta
- 1.30
- RSI (14)
- 66
- Avg Volume
- 443.82K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Trupanion delivered record third-quarter adjusted operating income and free cash flow, while accelerating pet acquisition efficiency, retention, and strategic investments in product, tech, and brand.· November 5, 2026
- Q3 total revenue was $405.6 million, up 11% year over year, and total adjusted operating income was $47 million, up 15%.
- Subscription revenue rose to $287.9 million, up 14%, with subscription AOI of $45.4 million and a 15.8% margin.
- Net new subscription pets topped 20.5 thousand, retention improved for a seventh straight quarter, and acquisition cost per pet fell to $279 from $290.
- Free cash flow hit an all-time high of $28.5 million; the company also repurchased about $25 million of stock and paid down $15 million of debt after quarter-end.
- Management raised full-year 2026 revenue and AOI guidance and said the new digital product remains on track for mid-2027, while Landspath advanced into limited trials for a 2027 launch.
Third-quarter 2026 revenue was $405.6 million, up 11% year over year. Subscription revenue was $287.9 million, up 14% year over year, and other business revenue was $117.7 million, up 3%. Total adjusted operating income was $47 million, up 15% year over year, while subscription adjusted operating income was $45.4 million, up 16%, with a 15.8% margin versus 15.5% last year. Net income was $9.3 million, or $0.21 per basic and diluted share, versus $5.9 million, or $0.14 per basic and $0.13 per diluted share, a year ago. Operating cash flow was $30.7 million, capital expenditures were $2.2 million, and free cash flow was $28.5 million, both company records. Subscription pets increased 6% year over year to 1.145 million, monthly average revenue per pet was $88.95, and trailing-12-month retention was 98.38%. For 2026, management now expects total revenue of $1.59 billion to $1.597 billion, subscription revenue of $1.131 billion to $1.133 billion, and total adjusted operating income of $179 million to $182 million. For Q4 2026, it guided to total revenue of $407 million to $414 million, subscription revenue of $297 million to $299 million, and total adjusted operating income of $48 million to $51 million.
Margie Tooth said the quarter reflected strong execution across growth, retention, and profitability, calling Q3 adjusted operating income and free cash flow all-time highs. She emphasized that investments in technology, automation, AI, brand, and product are improving conversion, member experience, and lifetime value, while still supporting a durable moat through direct vet payment and claims automation. She sounded constructive on the core business and said the new digital offering and Landspath both remain on track, with the new product targeted for mid-2027 and Landspath advancing toward a 2027 launch.
Fawwad Qureshi focused on the financial strength of the quarter: revenue of $405.6 million, adjusted operating income of $47 million, net income of $9.3 million, and free cash flow of $28.5 million. He highlighted that subscription cost of paying veterinary invoices was $200.6 million, variable expenses were 8.7% of subscription revenue, fixed expenses were 5.8%, and subscription AOI reached $45.4 million. He also noted the company repurchased about $25 million of stock in Q3, ended the quarter with $396.8 million of cash and short-term investments, had $104.5 million of total debt, and repaid $15 million of borrowings after quarter-end, leaving $18.5 million available on the credit facility. He raised full-year and Q4 guidance and said the company used a 72% conversion rate in projections.
Analysts pressed on why conversion improved, and management pointed to expanded coinsurance and deductible options, better online enrollment, and UX/AI-related improvements rather than a one-time campaign. On retention, management said seventh-straight-quarter improvement was broad-based across cohorts, though first-year retention can be a natural headwind because pet additions are running high. Questions on capital allocation drew a response that the company wants flexibility to keep investing in acquisition, technology, AI, and Landspath while opportunistically repurchasing shares and paying down debt. Analysts also asked about Landspath, and management said testing is underway, launch is expected around the middle of next year, and near-term revenue contribution should be very limited because the focus is on workflow, veterinary adoption, and logistics.
The company is showing both faster growth and better efficiency: net new pets, retention, ARPU, AOI, and free cash flow all improved, while acquisition spend per pet declined. Management also described several potential multi-year tailwinds, including broader product choice, higher conversion, more vet-clinic adoption of its software, and a new digital offering aimed at a wider market.
Management expects double-digit veterinary cost inflation to continue into 2027, and pricing will need to keep up to protect the value proposition. The new digital product is still months away, and Landspath is in limited trials with only very limited revenue expected over the next 18 months, so both initiatives remain early-stage. The Pets Best transition is also underway and will continue to roll off over time, which adds execution complexity.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 76.1%
- Shares Outstanding
- 43.27M
- Float Shares
- 32.93M
of shares held by institutions
208 13F filers
Buy/sell ratio 0.13. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for TRUP, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Brad SchneiderHouse · IL10 | Sell | Feb 8, 21 | Filing → |
| Brad SchneiderHouse · IL10 | Sell | Dec 7, 21 | Filing → |
| Brad SchneiderHouse · IL10 | Sell | Dec 10, 21 | Filing → |
| Brad SchneiderHouse · IL10 | — | Dec 10, 21 | Filing → |
| Marie NewmanHouse · IL03 | Sell | Jul 16, 21 | Filing → |
| Marie NewmanHouse · IL03 | Sell | May 21, 21 | Filing → |
| Brad SchneiderHouse · IL10 | Sell | Dec 17, 20 | Filing → |
| Brad SchneiderHouse · IL10 | Sell | Aug 12, 20 | Filing → |
| Brad SchneiderHouse · IL10 | Sell | Aug 12, 20 | Filing → |
| Brad SchneiderHouse · IL10 | Sell | Dec 17, 20 | Filing → |
| Brad SchneiderHouse · IL10 | Sell | Aug 12, 20 | Filing → |
| Brad SchneiderHouse · IL10 | Sell | Oct 30, 18 | Filing → |
| Brad SchneiderHouse · IL10 | Sell | Oct 10, 18 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 5.71M | ▲ 266.79K |
| Aflac Inc | 3.64M | 0 |
| Vanguard Group Inc | 3.51M | ▼ 48.59K |
| Capital World Investors | 2.15M | ▼ 1.69M |
| Fmr LLC | 1.94M | ▲ 900.29K |
| Vanguard Portfolio Management LLC | 1.79M | ▼ 15.88K |
| Polar Capital Holdings PLC | 1.75M | 0 |
| Vanguard Capital Management LLC | 1.49M | ▲ 8.21K |
| State Street Corp | 1.41M | ▲ 45.50K |
| Morgan Stanley | 1.00M | ▲ 100.78K |
| Geode Capital Management, LLC | 837.78K | ▼ 38.06K |
| Greenlea Lane Capital Management, LLC | 776.49K | 0 |
Held by 316 ETFs
Biggest fund positions in TRUP by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 13, 26 | Seawell Katherine | other | 44,843 |
| Nov 13, 26 | RUBIN HOWARD E | sell | 10,000 |
| Nov 16, 26 | RUBIN HOWARD E | sell | 10,000 |
| Nov 10, 26 | LOW MURRAY B | sell | 6,537 |
| Nov 9, 26 | Tooth Margaret | sell | 1,900 |
| Nov 9, 26 | Tooth Margaret | sell | 100 |
| Nov 9, 26 | RUBIN HOWARD E | sell | 30,000 |
| Oct 28, 26 | GALLAGHER JOHN R | sell | 431 |
| Oct 9, 26 | Tooth Margaret | sell | 1,000 |
| Sep 28, 26 | GALLAGHER JOHN R | sell | 431 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our TRUP coverage
Recent articles, reports, and earnings notes.
Want a deeper read on TRUP?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Fast-paced Momentum Stock Trupanion (TRUP) Is Still Trading at a Bargain
zacks.com · Nov 11
Trupanion, Inc. (TRUP) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 6
Trupanion Q3 Earnings Call Highlights
marketbeat.com · Nov 6
Trupanion (TRUP) Q3 Earnings and Revenues Beat Estimates
zacks.com · Nov 5
Trupanion (TRUP) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com · Nov 5
Trupanion Reports Third Quarter 2026 Results
globenewswire.com · Nov 5
5 Accident & Health Insurers to Watch Despite Cost Pressure
zacks.com · Nov 5
Trupanion (TRUP) Earnings Expected to Grow: Should You Buy?
zacks.com · Oct 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
